Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new ...

New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes BAAR, Switzerland & NEW YORK, February 26, ...

In part 1 of this three-part series, behavioral science reveals how slow patient recruitment and enrollment challenges often ...

LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed single ...

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...

BRCA1-Associated Protein 1 and Enhancer of Zeste Homolog 2: Pathway Interaction and Therapeutic Intervention in Breast Cancer, Mesothelioma, and Lymphoma Early-phase clinical trials (EPCTs) have been ...

Marginalized racial and ethnic groups, women, and other historically disenfranchised populations are substantially underrepresented in clinical trials, despite increasing concern about this issue ...

Evinova Study Designer empowers teams to design optimal studies in minutes using an AI-native solution. Evinova Study Designer brings together advanced data-driven intelligence and intuitive workflow ...